4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,219 | 92 | 1,366 | 14,580 | 2,000 |
| Gross Profit | 1,219 | 92 | 1,366 | 14,580 | 2,000 |
| Operating Expenses | 27,611 | 24,856 | 24,027 | 22,176 | 18,312 |
| Operating Income | -26,392 | -24,764 | -22,661 | -7,596 | -16,312 |
| Other Income | 54 | -319 | 422 | 7 | -94 |
| Pre-tax Income | -26,338 | -25,083 | -22,239 | -7,589 | -16,406 |
| Net Income Continuous | -26,338 | -25,083 | -22,239 | -7,589 | -16,406 |
| Net Income | $-26,338 | $-25,083 | $-22,239 | $-7,589 | $-16,406 |
| EPS Basic Total Ops | -0.82 | -0.86 | -0.82 | -0.28 | -0.61 |
| EPS Basic Continuous Ops | -0.82 | -0.85 | -0.82 | -0.28 | -0.61 |
| EPS Diluted Total Ops | -0.82 | -0.86 | -0.82 | -0.28 | -0.61 |
| EPS Diluted Continuous Ops | -0.82 | -0.85 | -0.82 | -0.28 | -0.61 |
| EBITDA(a) | $-25,404 | $-23,655 | $-22,281 | $-7,226 | $-15,929 |